Literature DB >> 26807761

Matricellular proteins as regulators of cancer metastasis to bone.

Timothy N Trotter1, Yang Yang2.   

Abstract

Metastasis is the major cause of death in cancer patients, and a frequent site of metastasis for many cancers is the bone marrow. Therefore, understanding the mechanisms underlying the metastatic process is necessary for future prevention and treatment. The tumor microenvironment is now known to play a role in the metastatic cascade, both at the primary tumor and in metastatic sites, and includes both cellular and non-cellular components. The extracellular matrix (ECM) provides structural support and signaling cues to cells. One particular group of molecules associated with the ECM, known as matricellular proteins, modulate multiple aspects of tumor biology, including growth, migration, invasion, angiogenesis and metastasis. These proteins are also important for normal function in the bone by regulating bone formation and bone resorption. Recent studies have described a link between some of these proteins and metastasis of various tumors to the bone. The aim of this review is to summarize what is currently known about matricellular protein influence on bone metastasis. Particular attention to the contribution of both tumor cells and non-malignant cells in the bone has been given.
Copyright © 2016 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone matrix; Bone metastasis; Bone microenvironment; ECM; Matricellular proteins

Mesh:

Substances:

Year:  2016        PMID: 26807761      PMCID: PMC4875810          DOI: 10.1016/j.matbio.2016.01.006

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  179 in total

1.  Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.

Authors:  C A Derosa; B Furusato; S Shaheduzzaman; V Srikantan; Z Wang; Y Chen; M Seifert; M Siefert; L Ravindranath; D Young; M Nau; A Dobi; T Werner; D G McLeod; M T Vahey; I A Sesterhenn; S Srivastava; G Petrovics
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-11-29       Impact factor: 5.554

2.  Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.

Authors:  Virginie Firlej; Jacques R R Mathieu; Cristèle Gilbert; Loïc Lemonnier; Jessica Nakhlé; Catherine Gallou-Kabani; Basma Guarmit; Aurélie Morin; Natalia Prevarskaya; Nicolas Barry Delongchamps; Florence Cabon
Journal:  Cancer Res       Date:  2011-10-28       Impact factor: 12.701

3.  Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.

Authors:  Abdullah Karadag; Kalu U E Ogbureke; Neal S Fedarko; Larry W Fisher
Journal:  J Natl Cancer Inst       Date:  2004-06-16       Impact factor: 13.506

Review 4.  Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family.

Authors:  Millicent M Sullivan; E Helene Sage
Journal:  Int J Biochem Cell Biol       Date:  2004-06       Impact factor: 5.085

5.  The effect of thrombospondin-1 on breast cancer metastasis.

Authors:  Karen O Yee; Caitlin M Connolly; Mark Duquette; Shideh Kazerounian; Raymond Washington; Jack Lawler
Journal:  Breast Cancer Res Treat       Date:  2008-04-13       Impact factor: 4.872

6.  Lumican expression, localization and antitumor activity in prostate cancer.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Claudia A Andrade de Paula; Celia R W Carneiro; Valdemar Ortiz; Leny Toma; Winston W-Y Kao; Helena B Nader
Journal:  Exp Cell Res       Date:  2013-02-08       Impact factor: 3.905

7.  Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways.

Authors:  Yunping Hu; Haiguo Sun; Rick T Owens; Jiansheng Wu; Yong Q Chen; Isabelle M Berquin; Donna Perry; Joseph T O'Flaherty; Iris J Edwards
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

Review 8.  Revisiting the matricellular concept.

Authors:  Joanne E Murphy-Ullrich; E Helene Sage
Journal:  Matrix Biol       Date:  2014-07-24       Impact factor: 11.583

9.  WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer.

Authors:  Kun-Chun Chiang; Chun-Nan Yeh; Li-Chuan Chung; Tsui-Hsia Feng; Chi-Chin Sun; Miin-Fu Chen; Yi-Yin Jan; Ta-Sen Yeh; Shin-Cheh Chen; Horng-Heng Juang
Journal:  Sci Rep       Date:  2015-03-03       Impact factor: 4.379

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

View more
  5 in total

Review 1.  Extracellular matrix: The driving force of mammalian diseases.

Authors:  Renato V Iozzo; Maria A Gubbiotti
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

Review 2.  Evolution of the Marrow Adipose Tissue Microenvironment.

Authors:  Clarissa S Craft; Erica L Scheller
Journal:  Calcif Tissue Int       Date:  2016-07-01       Impact factor: 4.333

Review 3.  Megakaryocytes in Bone Metastasis: Protection or Progression?

Authors:  Paola Maroni
Journal:  Cells       Date:  2019-02-08       Impact factor: 6.600

4.  Evaluation of breast cancer stem cells in human primary breast carcinoma and their role in aggressive behavior of the disease.

Authors:  Ninjit Dhanota; Amanjit Bal; Gurpreet Singh; Sunil K Arora
Journal:  J Clin Transl Res       Date:  2021-09-29

5.  Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression.

Authors:  Chia-Hung Hsu; Hon-Ping Ma; Jiann Ruey Ong; Ming-Shou Hsieh; Vijesh Kumar Yadav; Chi-Tai Yeh; Tsu-Yi Chao; Wei-Hwa Lee; Wen-Chien Huang; Kuang-Tai Kuo; Iat-Hang Fong; Chih-Cheng Lin; Chih-Ming Su
Journal:  Dis Markers       Date:  2022-07-19       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.